PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
1620.28%
Some net income increase while JHX is negative at -46.30%. John Neff would see a short-term edge over the struggling competitor.
27.95%
D&A growth well above JHX's 4.22%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
No Data
No Data available this quarter, please select a different quarter.
23.14%
Less SBC growth vs. JHX's 86.05%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
200.00%
Well above JHX's 78.21% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
-363.96%
AR is negative yoy while JHX is 2065.66%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
116.72%
Inventory growth well above JHX's 100.32%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
No Data
No Data available this quarter, please select a different quarter.
200.00%
Growth well above JHX's 85.10%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-190.32%
Negative yoy while JHX is 39.33%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
318.04%
Some CFO growth while JHX is negative at -3.19%. John Neff would note a short-term liquidity lead over the competitor.
-18.06%
Negative yoy CapEx while JHX is 26.43%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
80.16%
Acquisition growth of 80.16% while JHX is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-137.77%
Both yoy lines negative, with JHX at -620000100.00%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-1.45%
We reduce yoy invests while JHX stands at 23.88%. Joel Greenblatt sees near-term liquidity advantage unless competitor’s expansions yield high returns.
-200.00%
Both yoy lines negative, with JHX at -0.09%. Martin Whitman suspects an environment prompting net new borrowings or weaker paydowns across the niche.
No Data
No Data available this quarter, please select a different quarter.
200.00%
Repurchase growth above 1.5x JHX's 0.13%. David Dodd would see a strong per-share advantage if the share price is reasonably valued.